Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
European Journal of Cancer Care|October 3, 2018
Lung cancer in Spanish women: The WORLD07 projectPilar Garrido, Nuria Viñolas, Dolores Isla, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|April 15, 2023
[New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology]Dolores Isla, María D Lozano, Luis Paz-Ares, et al.
Lung Cancer (Amsterdam, Netherlands)|June 17, 2008
Retrospective study of efficacy and toxicity on patients older than 70 years within a randomized clinical trial of two cisplatin-based combinations in patients with small-cell lung cancerMaría José Safont, Angel Artal-Cortes, Rafael Sirera, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|July 12, 2020
[Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: A National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology]Fernando López-Ríos, Luis Paz-Ares, Julián Sanz, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 26, 2022
New update to the guidelines on testing predictive biomarkers in non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical OncologyDolores Isla, Maria D Lozano, Luis Paz-Ares, et al.
NPJ Precision Oncology|June 30, 2020
Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordanceLee S Schwartzberg, Hidehito Horinouchi, David Chan, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 27, 2010
SEOM clinical guidelines for the treatment of metastatic breast cancerIsabel Alvarez López, Juan de la Haba Rodríguez, Amparo Ruiz Simón, et al.
Clinical Lung Cancer|July 28, 2016
Efficacy and Safety Results From a Phase II, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy for Advanced Squamous Cell Non-Small-Cell Lung CancerFred R Hirsch, Ramaswamy Govindan, Zanete Zvirbule, et al.
Oncology and Therapy|January 15, 2022
Addition of Immune Checkpoint Inhibitors to Chemotherapy vs Chemotherapy Alone as First-Line Treatment in Extensive-Stage Small-Cell Lung Carcinoma: A Systematic Review and Meta-AnalysisEdurne Arriola, María González-Cao, Manuel Domine, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|June 19, 2025
Recommendations for diagnosis and management of non-small-cell lung carcinoma patients with ex20ins EGFR mutations: insights from a Delphi consensusDolores Isla, Esther Conde, Atocha Romero, et al.
Pageof 15